Pharmaceutical Industry in the
Canton of Fribourg

Corden Pharma Fribourg SA

Since 1951 · 101–500 empl.·4.1(15)

Corden Pharma Fribourg SA is a GMP CDMO providing development and manufacturing of active pharmaceutical ingredients (APIs), drug products and lipid excipients. Its services include integrated supply, formulation, analytical and packaging capabilities and technology platforms for peptides, oligonucleotides, lipids/LNPs, injectables, highly potent oncology compounds and small molecules.

UCB-Pharma SA

Since 2004 · 51–100 empl.·4.2(17)

UCB-Pharma SA is a pharmaceutical company that manufactures medicines for allergies, epilepsy and autoimmune diseases. It operates pharmaceutical, chemical synthesis and biotechnology production platforms and supplies these products to the healthcare market.

Phytopharma S.A.

Since 1993 · 11–20 empl.·4.8(9)

The core activity of Phytopharma AG is the development, manufacture and marketing of health products, including dietary supplements, medical devices, cosmetics and other health products, which are sold in pharmacies, drugstores and health food stores in Switzerland.

UCB Farchim SA

Since 1996 · 11–20 empl.·4.2(17)

UCB Farchim SA manufactures medicines for allergies, epilepsy and autoimmune diseases and operates pharmaceutical, chemical‑synthesis and biotechnological production platforms. The company focuses on producing medicines while ensuring product quality and safety.

Vifor Pharma Switzerland SA

Since 2021 · 11–20 empl.·4.2(15)

Vifor Pharma Switzerland SA is a pharmaceutical company that develops, manufactures and commercialises therapies and products for iron deficiency, nephrology and cardiorenal conditions. The company conducts research and development, licensing, regulatory and commercial activities, and provides information for patients and healthcare professionals as well as an online webshop.

Dehly S.A.

Since 1985 · 1–10 empl.

The core activity of Dehly SA is the development, manufacture and marketing of pharmaceutical lozenges, particularly based on gum arabic and plant-based ingredients. The company also offers services such as product development, prototype production, sensory testing and support for product registration.

Medistri SA

Since 2006 · 11–20 empl.

The core activity of Medistri is to provide sterilization and laboratory services to the healthcare industry, particularly to companies in the fields of pharmacy, medical technology, biotechnology, and aerospace. This includes specialized services such as sterilization, manufacturing, packaging, validation, and laboratory services. The company supports customers in the development and scaling of healthcare products and provides infrastructure for start-ups and established companies to facilitate their global expansion.

GBT Pharma GmbH

Since 2010 · 1–10 empl.

The core activity of GBT Pharma is the development of international markets for consumer healthcare products, particularly in the over-the-counter (OTC) segment. The company supports its customers in international market entry and development, including product development and marketing.

Chiesi SA

Since 2015 · 1–10 empl.

The core activity of OM Pharma Schweiz is the development, manufacture and marketing of pharmaceuticals, particularly for the treatment of urinary tract infections, respiratory diseases and central nervous system disorders. The company offers specific products such as Trimbow and Uro-Vaxom and primarily targets healthcare professionals in Switzerland.

OM Pharma Suisse SA

Since 2020 · 101–500 empl.·3.9(10)

OM Pharma Suisse SA develops and commercializes medicines based on bacterial lysates to prevent and manage recurrent respiratory and urinary tract infections and to treat certain vascular conditions. The company conducts research, manufactures bacterial lysate products and collaborates with international distribution partners.

Boiron SA

Since 2022 · 1–10 empl.

Creso Pharma Switzerland GmbH

Since 2023 · 1–10 empl.